CMHC Pulse Blog

More Aggressive Management of Hypertension Reduces Rates of CVD, Lowers Mortality Risk

Initial results of SPRINT (Systolic Blood Pressure Intervention Trial), a landmark clinical trial sponsored by the NIH, have shown that more aggressive management of hypertension significantly reduces the rate of cardiovascular disease and lowers the risk of mortality in a group of adults 50 years of age and older with hypertension. The trial, which began in 2009, consisted of more than 9300 participants 50 years of age and older. Participants were divided into two groups. The standard group, with a target systolic blood pressure of less than 140 mmHg, received an average of two different antihypertensive medications. The intensive treatment group received an average of three antihypertensive medications for a target systolic blood pressure of less than 120 mmHg.

Compared with the standard group, the intensive treatment group experienced an almost one-third reduction in rates of cardiovascular events, including myocardial infarction and heart failure as well as stroke. Risk of mortality was reduced by almost one fourth.

For the most up-to-date information on this study as well as other developments, plan to attend the Hypertension and Cardio-Renal Syndrome session at the 10th Annual CMHC on Friday, October 23.

Reference: Landmark NIH study shows intensive blood pressure management may save lives.

Subscribe to "The Monthly Beat" Newsletter

Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.

A division of Tarsus Medical owned by Tarsus Group
Connect

Cardiometabolic Health Congress
1801 N Military Trail, Ste 200
Boca Raton, FL, 33431

Copyright © 2021, Cardiometabolic Health Congress. All Rights Reserved.

Subscribe

Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.